4//SEC Filing
Li Ting 4
Accession 0001104659-21-137162
CIK 0001563665other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 8:37 PM ET
Size
8.1 KB
Accession
0001104659-21-137162
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Li Ting
Director
Transactions
- Award
Stock Option (right to buy)
2021-07-01+22,500→ 22,500 totalExercise: $1.35Exp: 2031-07-01→ Common Stock, par value $0.01 per share (22,500 underlying) - Award
Stock Option (right to buy)
2021-07-01+18,035→ 40,535 totalExercise: $1.35Exp: 2031-07-01→ Common Stock, par value $0.01 per share (18,035 underlying)
Footnotes (2)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 1, 2021, January 1, 2022, April 1, 2022 and July 1, 2022.
- [F2]This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, October 1, 2021, January 1, 2022 and April 1, 2022.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeother
Related Parties
1- filerCIK 0001759813
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 8:37 PM ET
- Size
- 8.1 KB